pre-seed
Stage
About
Saccharo, Inc is a preclinical stage oncology company developing antibody-drug conjugates targeting a novel polysaccharide-based immune shielding pathway (dPSA) expressed specifically on cancer cells for the treatment of solid tumors and hematologic cancers.
Explore Saccharo, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.